These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 836506)
21. Biological activity of des-asp1-angiotensin II (angiotensin III) in man. Kono T; Oseko F; Shimpo S; Nanno M; Endo J J Clin Endocrinol Metab; 1975 Dec; 41(06):1174-7. PubMed ID: 1206103 [TBL] [Abstract][Full Text] [Related]
22. The amino acid composition of angiotensin alters its ability to reduce alcohol consumption in rats. Ross AD; Perlanski E; Grupp LA Alcohol; 1991; 8(5):349-54. PubMed ID: 1797031 [TBL] [Abstract][Full Text] [Related]
23. Effect of lipophilic character on the biological activity of synthetic angiotensin peptides. Nouailhetas VL; Nakaie CR; Juliano L; Paiva AC Biochem J; 1977 Sep; 165(3):547-51. PubMed ID: 921765 [TBL] [Abstract][Full Text] [Related]
24. Effect of Asp1-beta-amide-Val5-angiotensin II, Sar1-lle5-angiotensin II and (N,N-dimethyl) Gly1-lle5-angiotensin II on isolated perfused rabbit kidney. Ercan ZS; Türker RK; Bökesoy TA Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):237-46. PubMed ID: 4376677 [No Abstract] [Full Text] [Related]
25. Synthesis of angiotensin II antagonists containing sarcosine in position 7. Moore GJ; Oudeman EM; Ko D; Nystrom DM J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin II-induced endothelium-dependent relaxation of fowl aorta. Hasegawa K; Nishimura H; Khosla MC Am J Physiol; 1993 May; 264(5 Pt 2):R903-11. PubMed ID: 8498599 [TBL] [Abstract][Full Text] [Related]
27. Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor. Zou LX; Imig JD; Hymel A; Navar LG Am J Hypertens; 1998 May; 11(5):570-8. PubMed ID: 9633793 [TBL] [Abstract][Full Text] [Related]
28. [Asp1, Val5] angiotensin-(1-8)octapeptide does not stimulate aldosterone secretion in sodium-depleted sheep. Scoggins BA; McDougall JG; Butkus A; Coghlan JP; Denton DA; Hardy KJ; Wright RD Clin Sci (Lond); 1981 Jul; 61(1):111-3. PubMed ID: 7249550 [TBL] [Abstract][Full Text] [Related]
29. [Synthesis and biological activity of cyclic analogs of angiotensin]. Bisenietse DA; Antsans IuE; Myshliakova NV; Kublik GG; Porunkevich EA Bioorg Khim; 1987 Feb; 13(2):149-59. PubMed ID: 2437929 [TBL] [Abstract][Full Text] [Related]
30. Angiotensin II analogues. 12. Role of the aromatic ring of position 8 phenylalanine in pressor activity. Hsieh K; Jorgensen EC; Lee TC J Med Chem; 1979 Sep; 22(9):1038-44. PubMed ID: 490548 [No Abstract] [Full Text] [Related]
31. Angiotensin II vascular receptors in fowl aorta: binding specificity and modulation by divalent cations and guanine nucleotides. Stallone JN; Nishimura H; Khosla MC J Pharmacol Exp Ther; 1989 Dec; 251(3):1076-82. PubMed ID: 2600804 [TBL] [Abstract][Full Text] [Related]
32. Further studies on the stimulation of rat adrenal capsular cells: four types of response. Tait JF; Tait SA; Bell JB; Hyatt PJ; Williams BC J Endocrinol; 1980 Oct; 87(1):11-27. PubMed ID: 6253588 [TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530 [TBL] [Abstract][Full Text] [Related]
34. Differential effect of vasopressin on angiotensin and norepinephrine pressor action in rats. Elijovich F; Barry CR; Krakoff LR; Kirchberger M Am J Physiol; 1984 Dec; 247(6 Pt 2):H973-7. PubMed ID: 6507644 [TBL] [Abstract][Full Text] [Related]
35. Characterization of angiotensin I, II, and III from mouse as position-5 isoleucine [Ile5] angiotensins. An HPLC Study. Jacobsen J; Poulsen K J Hypertens; 1985 Apr; 3(2):155-7. PubMed ID: 4020123 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterization, and biological activity of N alpha-(N-fluoresceinthiocarbamoyl)-(Asp1, Ile5)-angiotensin II. Barnes LD; Guy MN; Roberson GM; Osgood RW Arch Biochem Biophys; 1982 Mar; 214(1):239-47. PubMed ID: 7081999 [No Abstract] [Full Text] [Related]
37. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I. Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926 [No Abstract] [Full Text] [Related]
38. Competitive inhibition of Asp1-beta-amide-Val5-angiotensin II by Sar1-Ile5-Ile8-angiotensin II in cat isolated cardiac muscle and coronary vessels. Türker RK; Hall MM; Bumpus FM J Pharm Pharmacol; 1974 Aug; 26(8):582-7. PubMed ID: 4155722 [No Abstract] [Full Text] [Related]
39. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II. Scanlon MN; Matsoukas JM; Franklin KJ; Moore GJ Life Sci; 1984 Jan; 34(4):317-21. PubMed ID: 6546405 [TBL] [Abstract][Full Text] [Related]
40. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II. O'Connor GJ; Baranowski RL; Kurtzman NA Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]